Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NFL-101 on Reduction of Reinforcing Properties of Cigarettes in Smokers
NCT06091826Phase 2Completed
- Sponsor
- NFL Biosciences
- Start
- Feb 2023
- Primary completion
- Sep 2023
- Modality
- Botanical drug
- Countries
- 1
01
Overview
A Phase 2 trial of nfl-101 in nicotine dependence, sponsored by NFL Biosciences. Started Feb 2023; status: completed.
02
Drugs
nfl-101
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT06091826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06091826.